Immunotherapy for hepatocellular carcinoma recurrence after liver transplantation, can we harness the power of immune checkpoint inhibitors?

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death globally and liver transplantation (LT) can serve as the best curative treatment option. However, HCC recurrence after LT remains the major obstacle to the long-term survival of recipients. Recently, immune checkpoin...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Jingyu, Huang, Haitao, Chen, Ruihan, Lin, Yimou, Ling, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978931/
https://www.ncbi.nlm.nih.gov/pubmed/36875077
http://dx.doi.org/10.3389/fimmu.2023.1092401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978931/
https://www.ncbi.nlm.nih.gov/pubmed/36875077
http://dx.doi.org/10.3389/fimmu.2023.1092401

Ejemplares similares